1. American College of Obsetetricians and Gynecologists. Invasive prenatal testing for aneuploidy. ACOG Practice Bulletin 88, Washington, DC: Dec 2007. 2. Grimes DA, Schultz KF. Morbity and mortality from second trimester abortion. J Repro Med 1985;30:505–14. 3. Sundberg K, Bang J, Smidt–Jensen S et al.. Randomized study of risk of fetal loss
related to early amniocentesis versus chorionic villus sampling. Lancet 1997;350:697–703. 4. CEMAT Group. Randomized trial to assess safety and fetal outcomes of early and midtrimester amniocentesis. Lancet 1998;351:
1435. 5. Evans MI, Andriole S. Chorionic villus sampling and amniocentesis in 2008. Curr Opin Obstet Gynecol 2008;20(1):164–8. 6. Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006;18:612–6. 7. Spencer K, Souter V,
Tul N et al.. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free B–human chorionic gonadotrophin and pregnancy–assoicarted plasma protein A. Ultrasound Obstet Gynecol 1991;13:231–7. 8. Boehm FH, Salyer SL, Dev VG et al.. Chorionic villus sampling: quality control–m–A
continuous improvement model. Am J Obstet Gynecol 1993;168:1766–77. 9. Department of Obstetrics and Gynecology. Tietung Hospital of Anshan Iron and Steel Co. Anshan, China. Fetal sex prediction by sex chromatin of chorionic villi cells during early
pregnancy. Chinese Med J 1975;1:117. 10. Hahnemann N, Mohr J. Genetic diagnosis in the embryo by means of biopsy from extraembryonic membranes. Bull Eur Soc Hum Genet 1968;2:23–9. 11. Kullander S, Sandahl B. Fetal chromosome analysis after transcervical placental biopsies during early pregnancy. Acta Obstet Gynecol Scand 1973;52:355–9. 12. Hahnemann N. Early prenatal diagnosis: a study of biopsy techniques and cell culturing from extraembryonic membranes. Clin Genet 1974;6:294–306. 13. Kazy Z, Rozovsky I, Bakhaey V. Chorion biopsy in early pregnancy: a method of early prenatal diagnosis for inherited disorders. Prenat Diagn 1982;2:39–45. 14. Old J. First trimester fetal diagnosis for
haemoglobinopathies: three cases. Lancet 1982;2:1413–6. 15. Brambati B, Simoni G. Diagnosis of fetal trisomy 21 in first trimester. Lancet 1983;1:586. [PubMed:
6131275] 16. Canadian Collaborative CVS–Amniocentesis Clinical Trial Group. Multicentre randomized clinical trial of chorion villus sampling and amniocentesis. Lancet 1989;i:1. 17. Rhoads GG, Jackson IG, Schlesselman SE et al.. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989;320:609–9. 18. Committee on Genetics. ACOG Committee Opin 1995;160. 19. Jackson LG, Zachary JM, Fowler SE et al.. Randomized comparison of transcervical and transabdominal chorionic villus sampling. N Engl J Med 1992;327:594–8. 20. Silver RK, MacGregor SN, Sholl JS et al.. Initiating a chorionic villus sampling program. Relying on placental location as the primary determinant of the sampling
route. J Reprod Med 1990; 35:964–8. [PubMed: 2246764] 21. Brambati B, Oldrini A, Lanzani A. Transabdominal and trans–cervical chorionic villus sampling: efficiency and risk evaluation of 2,411 cases. Am J Med Genet 1990;35: 160–4. 22. Liu DT, Agbaje R, Preston C, Savage J. Intraplacental sonolucent spaces: Incidences and relevance to chorionic villus sampling. Prenat Diagn 1991;11:805. 23. Brambati B, Oldrini A, Lanzani A. Transabdominal chorionic villus sampling: a freehand ultrasound–guided technique. Am J Obstet Gynecol 1987;157:134. 24. Smidt–Jensen S,
Hahnemann N. Transabdominal chorionic villus sampling for fetal genetic diagnosis. Technical and obstetric evaluation of 100 cases. Prenat Diagn 1988;8:7. 25. Silver RK,
MacGregor SN, Sholl JS, Hobart ED, Waldee JK. An evaluation of the chorionic villus sampling learning curve. Am J Obstet Gynecol 1990;163:917–22. 26. Jackson LG, Wapner RJ. Risks of chorionic villus sampling. Clin
Obstet Gynecol 1987;1:513. 27. Brambati B, Oldrini A, Ferrazzi E et al.. Chorionic villus sampling: an analysis of the obstetric experience of 1000 cases. Prenat Diagn 1987;7:157–69. 28. Brambati
B,
Matarrelli M, Varotto F. Septic complications after chorionic villus sampling. Lancet 1987;i(8543):1212a. 29. Wass D, Bennett MJ. Infection and chorionic villus sampling. Lancet 1985;ii:338. 30. Scialli
AR, Neugebauer DL, Fabro SE. Microbiology of the endcervix in patients undergoing chorionic villus sampling. In: Fracearo M, Simoni G, Brambati B, eds. First Trimester Fetal Diagnosis. Berlin: Springer–Verlag, 1985:69–73. 31. Brambati B, Varotti F. Infection and chorionic villus sampling. Lancet 1985;ii:609. 32. Hogge WA, Schonberg SA, Golbus MS. Chorionic villus sampling: experience of the first 1000 cases. Am J Obstet Gynecol 1986;154:1249. 33. Gilmore DH, McNay MB. Spontaneous fetal loss rate in
early pregnancy. Lancet 1985;i:107. 34. Wilson RD, Kendrick V, Witmann BK. Risks of spontaneous abortion in ultrasonographically normal pregnancies. Lancet 1984;ii:920. 35. Barela A, Kleinman GE,
Golditch IM et al.. Septic shock with renal failure after chorionic villus sampling. Am J Obstet Gynecol 1986;154:1120. 36. Blakemore KJ, Mahoney MJ, Hobbins JC. Infection and chorionic villus sampling. Lancet 1985;2:339. [PubMed: 2862508]
37. Cheng EY, Luth DA, Hickok D et al.. Transcervical chorionic villus sampling and midtrimester oligohydramnios. Am J Obstet Gynecol 1991;165:1063. 38. Blakemore KJ, Baumgarten
A, Schoenfeld–Dimaio M et al.. Rise in maternal serum-alpha–fetoprotein concentration after chorionic villus sampling. Lancet 1985;ii:339. 39. Bramabati B, Guercilena S, Bonacchi I et al.. Fetomaternal transfusion after chorionic villus sampling: clinical implications. Hum Reprod 1986;1:37. 40. Shulman LP, Meyers CM, Simpson JL et al.. Fetomaternal transfusion depends on amount of chorionic villi aspirated but not on method of chorionic villus sampling. Am J Obstet Gynecol 1990;162:1185. 41. Smidt–Jensen S, Philip J, Zachary J et al.. Implications of maternal serum alpha–fetoprotein elevation caused by transabdominal and transcervical CVS. Prenat Diagn 1994;14:35–46. 42. Zipursky A, Israels LG. The pathogenesis and prevention of Rh immunization. Can Med Assoc J 1967;97:1245–57. [PubMed: 4168032] 43. Moise KJ, Carpenter RJ. Increased severity of fetal hemolytic disease with known
Rhesus alloimmunization after first trimester transcervical chorionic villus biopsy. Fetal Diagn Ther 1990;5:76. 44. Clark BA, Bissonnette J, Olson SB et al.. Pregnancy loss in a small chorionic villus sampling series. Am J Obstet Gynecol
1989;161:301. 45. Green JE, Dorfman A, Jones SL et al.. Chorionic villus sampling: experience with an initial 940 cases. Obstet Gynecol 1988;71:208.
[PubMed: 3336556] 46. Gustavii B, Claesson V, Kristoffersson U et al.. Risk of miscarriage after chorionic biopsy is probably not higher than after amniocentesis. Lakartidningen 1989;86:4221. [PubMed: 2593756] 47. Jahoda MGJ, Pijpers L, Reuss A et al.. Evaluation of transcervical
chorionic villus sampling with a completed follow–up of 1550 consecutive pregnancies. Prenat Diagn 1989;9:621. 48. Young SR, Shipley CF, Wade RV et al.. Single–center comparison of results of 1000 prenatal diagnoses with chorionic
villus sampling and 1000 diagnoses with amniocentesis. Am J Obstet Gynecol 1991;165:255. 49. Hogge WA, Schonberg SA, Golbus MS. Chorionic villus sampling: experience of the first 1000 cases. Am J Obstet Gynecol 1986;154:1
249–52. 50. Jackson LG. CVS Newslett 1988;25–7. 51. Wade RV, Young SR. Analysis of fetal loss after transcervical chorionic villus sampling: a review of 719 patients. Am J Obstet Gynecol 1989;161:513–9. 52. Warburton D, Fraser FC. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Hum Genet 1964;16:1–25. 53. Simpson JL, Mills ML, Holmes LB et al.. Low fetal loss rates after ultrasound–proved viability in early pregnancy. JAMA 1987;258:
2555–7. 54. Christiaens GC, Stoutenbeeck P. Spontaneous abortion in proven intact pregnancies. Lancet 1984;2:571–2. 55. Wilson RD, Kendrick V, Wirtman BP et al.. Spontaneous abortion and pregnancy outcome after normal first–trimester ultrasound examination. Obstet Gynecol 1986;67:352–5. [PubMed: 3511418] 56. Saura R, Gauthier
B, Taine L et al.. Operator experiences and fetal loss rate in transabdominal CVS. Prenat Diagn 1994;14:70. 57. Wapner RJ, Barr MA, Heeger S et al.. Chorionic villus sampling: a 10-year, over 13,000 consecutive case
experience (abstract). Presented at the First Annual Meeting of the American College of Medical Genetics, Orlando, Florida, March 1994. 58. Nicolaides K, Brizot M de L, Patel F, Snijders R. Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation. Lancet 1994;344(8920):435. 59. Brambati B, Lanzani A, Tului L. Transabdominal and transcervical chorionic villus sampling: efficacy and risk evaluation of 2411 cases. Am J Hum Genet 1990;35:160. 60. Brambati B, Terzian E, Tognoni G.
Randomized clinical trial of transabdominal versus transcervical chorionic villus sampling methods. Prenat Diagn 1991;11:285. 61. Smidt–Jensen S, Permin M, Philip J. Sampling success and risk by transabdominal chorionic villus sampling,
transcervical chorionic villus sampling and amniocentesis: a randomized study. Ultrasound Obstet Gynecol 1991;1:86. 62. Chueh JT, Goldberg JD, Wohlfered MM, Golbus MS. Comparison of transcervical and transabdominal
chorionic villus sampling loss rates in nine thousand cases from a single center. Am J Obstet Gynecol 1995;173:1277. 63. Firth HV, Boyd P, Chamberlain P et al.. Severe limb abnormalities after chorion villus sampling at 56-66 days
gestation. Lancet 1991;337:726. 64. Hoyme F, Jones KL, Van Allen MI et al.. Vascular pathogenesis of transverse limb reduction defects. J Pediatr 1982;101:839. 65. Foster–Iskenius U, Baird P. Limb reduction defects in over 1,000,000 consecutive live births. Teratology 1989;39:127. 66. Mastroiacovo P, Botto LD, Cavalcanti DP. Limb anomalies following chorionic villus sampling: a registry based case control study. Am J Med Genet 1992;44:856–63. 67. Brambati B, Simoni G, Traui M. Genetic diagnosis by
chorionic villus sampling before 8 gestational weeks: efficiency, reliability, and risks on 317 completed pregnancies. Prenat Diagn 1992;12:784–99. 68. Hsieh FJ, Shyu MK, Sheu BC et al.. Limb defects after chorionic villus sampling. Obstet Gynecol 1995;85:84. 69. Burton BK, Schultz CJ, Burd LI. Spectrum of limb disruption defects associated with chorionic villus sampling. Pediatrics 1993;91:989–93. [PubMed: 8474823] 70. Froster UG, Jackson L. Limb defects and chorionic villus sampling: results from an international registry. 1992-1994.
Lancet 1996; 347(9000):489. 71. Brent RL. Relationship between uterine vascular clamping, vascular disruption syndrome and cocaine teratology. Teratology 1990;41:
757. 72. Webster W, Brown–Woodman T. Cocaine as a cause of congenital malformations of vascular origin: experimental evidence in the rat. Teratology 1990;41:689. 73. Quintero R, Romero R, Mahoney M et al.. Fetal haemorrhagic lesions after chorionic villus sampling. Lancet 1992;339:193. 74. Quintero RA, Romero R, Mahoney MJ et al.. Embryoscopic demonstration of hemoagic lesions on the human embryo after placental tauma. Am J Obstet Gynecol 1993;168:756–9. 75. Firth HV, Boyd PA, Chamberlain PF et al.. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 1994;343(8905):1069. 76. Olney RS, Khoury MJ, Alo CJ et al.. Increased risk for transverse digital deficiency after chorionic villus sampling: results of the United States Multistate Case–Control Study. 1988-1992. Teratology 1995;5(1):20–9. 77. Williams J, Medearis AL, Bear MD et
al.. Chorionic villus sampling is associated with normal fetal growth. Am J Obstet Gynecol 1987; 157:708. 78. Jahoda MGJ, Brandenberg H, Cohen–Overbeek TE et al.. Terminal transverse limb defects and early chorionic villus
sampling: evaluation of 4,300 cases with completed follow–up. Am J Med Genet 1993;46:483. 79. Halliday J, Lumley J, Sheffield LJ et al.. Limb deficiencies, chorion villus sampling, and advanced maternal age. Am J Med Genet 1993;47:1096. 80. Schloo R, Miney P, Holzgreve W et al.. Distal limb deficiency following chorionic villus sampling? Am J Med Genet 1992;42:404. 81. Monni G, Ibba RM, Lai R et al.. Limb–reduction defects and chorion villus sampling. Lancet 1991;337:1091. 82. Blakemore K, Filkins K, Luthy DA et al.. Cook Obstetrics and Gynecology Catheter Multicenter Chorionic Villus Sampling Trial: Comparison of birth defects with expected rates. Am J Obstet Gynecol 1993;169:1022. 83. Silver RK, Macgregor SN, Muhlbach LH et al.. Congenital malformations subsequent to chorionic villus sampling: outcome analysis of 1048 consecutive procedures. Prenat Diagn 1994;14:421. 84. Mahoney MJ for the USNICHD Collaborative CVS Study Group. Limb abnormalities and chorionic villus sampling. Lancet 1991;37:1422. 85. Jackson LG, Wapner RJ, Brambati B. Limb abnormalities and chorionic villus sampling. Lancet 1991;337:1423. 86. Smidt–Jensen S, Permin
M, Philip J et al.. Randomized comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling. Lancet 1992;340:1237. 87. Bissonnette JM, Busch WL, Buckmaster JG et al.. Factors
associated with limb anomalies after chorionic villus sampling (letter). Prenat Diagn 1993;13:1163–5. 88. Dolk H, Bertrend F, Lechat MF. Chorionic villus sampling and limb abnormalities. The EUROCAT Working Group. Lancet 1992;
339:876. 89. Burton BK, Schulz CH, Burd LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol 1992;79:726. [PubMed: 1565357]
90. Mastroiacovo P, Tozzi AE, Agosti S et al.. Transverse limb reduction defects after chorion villus sampling: a retrospective cohort study. Prenat Diagn 1993;13:1051. 91. Mastroiacovo
P, Botto LD. Chorionic villus sampling and transverse limb deficiencies: maternal age is not a confounder. Am J Med Genet 1994;53:182. 92. Angue H, Bingru Z, Hong W. Long–term follow–up results after aspiration of chorionic villi
during early pregnancy. In: Fraccaro M, Simoni G, Brambati B, eds. First Trimester Fetal Diagnosis. New York: Springer, 1995:1. 93. Martin AO, Simpson JL, Rosinksy BJ et al.. Chorionic villus sampling in continuing pregnancies II: cytogenetic reliability. Am J Obstet Gynecol 1986;154:1653–62. 94. Simoni G, Gimelli G, Cuoco C et al.. Discordance between prenatal
cytogenetic diagnosis after chorionic villi sampling and chromosomal constitution of the fetus. In: Fraccaro M, Simoni G, Brambati B, eds. First Trimester Fetal Diagnosis. Heidelberg: Springer–Verlag, 1985:137–43. 95. Cheung SW, Crane JP, Beaver HA et al.. Chromosome mosaicism and maternal cell contamination in chorionic villi. Prenat Diagn 1987;7:535–42. 96. Ledbetter DH, Martin AO, Verlinsky Y et al.. Cytogenetic results of chorionic villus sampling: high success rate and diagnostic accuracy in the United States collaborative study. Am J Obstet Gynecol 1990;162:495. 97. Mikkelsen M, Ayme S. Chromosomal findings in chorionic villi. In: Vogel F, Sperling K, eds. Human Genetics. Heidelberg: Springer–Verlag, 1987:597. 98. Simoni G, Brambati B, Danesino C
et al.. Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet 1983;63:349. 99. Ford JH, Jahnke AB. Handling of chorionic villus for direct chromosome studies.
Lancet 1983;2:1491. 100. Gregson NM, Seabright N. Handling of chorionic villi for direct chromosome studies. Lancet 1983;2:1491. 101. Chang HC, Jones OW, Masui H. Human amniotic fluid cells grown in a hormone–supplemented medium: suitability for prenatal diagnosis. Proc Natl Acad Sci U S A 1982;79:4795. 102. Hogge WA, Schonberg SA, Golbus MS. Prenatal diagnosis by chorionic villus sampling: lessons of the first 600 cases. Prenat Diagn 1985;5:393. 103. Williams J, Madearis AL, Chun WH et al.. Maternal cell contamination in cultured chorionic villi: comparison of chromosome-Q–polymorphisms derived from villi, fetal skin, and maternal lymphocytes. Prenal Diagn 1987;7:315. 104. Ledbetter DH, Zachary JL, Simpson MS et al.. Cytogenetic results from the U.S. collaborative study on CVS. Prenat Diagn 1992;12:317. 105. Elles RG, Williamson R, Niazi D et al.. Absence of maternal
contamination of chorionic villi used for fetal gene analysis. N Engl J Med 1983;308:1433. 106. Karkut I, Zakrzewski S, Sperling K. Mixed karyotypes obtained by chorionic villi analysis: mosaicism and maternal contamination. In: Fraccaro
M, Simoni G, Brambati B, eds. First Trimester Fetal Diagnosis. Heidelberg: Springer–Verlag, 1985:144–6. 107. Markert C, Petters R. Manufactured hexaparenteral mice show that adults are derived from three embryonic cells. Science 1978;202:56. 108. Wolstenholine J. Confined placental mosaicism for trisomies 2, 3, 7, 8, 9, 16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization. Prenat Diag 1996;16:511. 109. Cassidy SB, Lai LW, Erickson RP et al.. Trisomy 15 with loss of the paternal 15 as a
cause of Prader–Willi syndrome due to maternal disomy. Am J Hum Genet 1992;51:701. [PubMed: 1357962] 110. Purvis–Smith SG, Sayille T, Manass S et al.. Uniparental disomy 15 resulting from "correction" of an initial trisomy 15. Am J Hum Genet 1992;50:1348. [PubMed:
1598916] 111. Ledbetter DH, Engel E. Uniparental disomy in humans: development of an imprinting map and its implications for prenatal diagnosis. Hum Mol Genet 1995;4:1757–64. [PubMed: 8541876] 112. Kalousek DK, Dill FJ, Pantzar T et al.. Confined chorionic mosaicism in prenatal diagnosis. Hum
Genet 1987;77:163. 113. Johnson A, Wapner RJ, Davis GH et al.. Mosaicism in chorionic villus sampling: an association with poor perinatal outcome. Obstet Gynecol 1990;75:573. [PubMed: 2314775] 114. Wapner RJ, Simpson MS, Golbus MS et al.. Chorionic mosaicism: association with fetal loss but not with adverse perinatal outcome. Prenat Diagn 1992;12:347. 115. Goldberg JD, Proter AE, Golbus MS. Current assessment of fetal losses as a direct consequence of chorionic villus sampling. Am J Med Genet 1990;35:174. 116. Kalousek DK, Howard–Pebbles PN, Olson SB et al..
Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism. Prenat Diagn 1991;11:743. 117. Worton RG, Stern RA. Canadian collaborative study of mosaicism in
amniotic fluid cell cultures. Prenat Diagn 1984;4:131. 118. Kalousek DK, Langlois S, Barrett I et al.. Uniparental disomy for chromosome 16 in humans. Am J Hum Genet 1993;52:8. [PubMed: 8434609] 121. Vejerslev LO, Mikkelsen M. The European collaborative study on mosaicism in chorionic villus sampling: data from 1986-1987. Prenal Diagn 1989;9:575. 122. Breed ASPM, Mantingh A, Vosters R et al..
Follow–up and pregnancy outcome after a diagnosis of mosaicism in CVS. Prenat Diagn 1991;11:577. 123. Phillips OP, Tharapel AT, Lerner JL et al.. Risk of fetal mosaicism when placental mosaicism is diagnosed by chorionic villus
sampling. Am J Obstet Gynecol 1996;174:850. 124. Bartels I, Hansmann I, Holland U et al.. Down syndrome at birth not detected by first trimester chorionic villus sampling. Am J Med Genet 1989;34:606. 125. Lilford RJ, Caine A, Linton G et al.. Short–term culture and false–negative results for Down's syndrome on chorionic villus sampling. Lancet 1991;337:861. 126. Miny P, Basaran S, Holzgreve W et al.. False–negative cytogenetic result in direct preparations after CVS. Prenat Diagn 1988;8:633. 127. Simoni G, Fraccaro M, Gimelli G et al.. False–positive and false–negative findings on chorionic villus sampling. Prenat Diagn 1987;7:671. 128. Martin AO, Elias S, Rosinsky B et al.. False–negative findings on chorion villus sampling. Lancet 1986;2:391. 129. Grebner EE, Jackson LG. Prenatal diagnosis for Tay–Sachs disease using chorionic villus sampling. Prenat Diagn 1985;5:313. 130. Galjaard H. Biochemical analyses of chorionic villi: a worldwide survey of first trimester fetal diagnosis of inborn errors of metabolism. In: Fraccaro M, Simoni G, Brambati B, eds. First Trimester Fetal Diagnosis. Berlin: Springer–Verlag, 1985:205. 131. Gray RG, Green A, Cole T et
al.. A misdiagnosis of X–linked adrenoleukodystrophy in cultured chorionic villus cells by the measurement of very long chain fatty acids. Prenat Diagn 1995;15:486. 132. Castellvi–Bel S, Mila M, Solor A et al.. Prenatal diagnosis of
fragile X syndrome: expansion and methylation of chorionic villus samples. Prenat Diagn 1995;15:801. 133. Wapner RJ, Johnson A, Davis G et al.. Prenatal diagnosis in twin gestations: a comparison between second trimester amniocentesis
and first trimester chorionic villus sampling. Obstet Gynecol 1993;82:49–56. [PubMed: 8515925] 134. Pergament E, Schulman J, Copeland K et al.. The risk of and efficacy of chorionic villus sampling in multiple gestations. Prenat Diagn 1992;12:377–84. 135. Evans MI, Goldberg J, Horenstein J et al.. Selective termination for structural chromosomal and mendelian anomalies: International experience. Obstet Gynecol 1999;180:S31. 136. Evans MI, Wapner RJ,
Carpenter R et al.. International collaboration on multifetal pregnancy reduction: dramatically improved outcomes with increased experience. Obstet Gynecol 1999;180:S28. 137. Brambati B, Tului L, Lanzana A et al.. First trimester gentic diagnosis in multiple pregnancies: principles and potential pitfalls. Prenat Diagn 1991;11:767–74. |
After amniocentesis the sonographer should demonstrate and document which one of the following
zusammenhängende Posts
Urheberrechte © © 2024 de.apacode Inc.
